Skip to main content

Table 2 MDA, SOD, GSH-Px concentration and ALT, AST levels in CHC patients before and after the treatment. (Mean ± Standard Deviation)

From: Oxidative stress and antioxidant defense in patients with chronic hepatitis C patients before and after pegylated interferon alfa-2b plus ribavirin therapy

  CHC Patients Before Treatment CHC Patients After treatment P-value
MDA 9,28 ± 1,61 4,88 ± 1,22 <0.001
CuZn-SOD 213,84 ± 71,61 357,94 ± 82,10 <0.001
GSH-Px 6,52 ± 1,86 9,47 ± 1,82 <0.001
ALT 95.84 ± 22.68 26,73 ± 10,65 <0.001
AST 80.52 ± 19.27 25,52 ± 8,68 <0.001
  1. Values are shown as means, p values (<0.05) were derived by the Paired-Simple T-test Independent Samples T-test. Units were expressed as follows: MDA as nmol/ml; CuZn-SOD as U/ml,; GSH-Px as U/ml; ALT, AST as U/L.